Email this article Prevention of bone metastases in breast cancer
- Authors: Kogonia L.M.1
-
Affiliations:
- Cancer Dispensary Two, Moscow
- Issue: No 3 (2010)
- Pages: 24-26
- Section: PHARMACOTHERAPY
- Published: 28.08.2010
- URL: https://ojrs.abvpress.ru/ojrs/article/view/246
- DOI: https://doi.org/10.17650/1994-4098-2010-0-3-24-26
- ID: 246
Cite item
Full Text
Abstract
The paper deals with the prevention of bone metastases in patients with breast cancer (BC). The drugs from a group of bisphosphonates are ascertained to play an important role in combination therapy for bone metastases. Bonefos (clodronate) is one of these agents used in BC patients for prophylaxis.
Keywords
About the authors
L. M. Kogonia
Cancer Dispensary Two, Moscow
Author for correspondence.
Email: Lali51@yandex.ru
Russian Federation
References
Supplementary files
